Conditions: Benign Prostatic Hyperplasia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 612
Healthy volunteers: no

Brief summary:
This study is a randomized, double-blind, placebo and tamsulosin-controlled, parallel design, multinational study to evaluate the efficacy and safety of Tadalafil once-a-day dosing for 12 weeks in Asian men with signs and symptoms of benign prostatic hyperplasia (BPH).

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: Tadalafil intervention 2: Placebo intervention 3: Tamsulosin
Intervention descriptions: intervention 1: by mouth (PO), once daily (QD) (30 min after meal) for 12 weeks intervention 2: PO, QD (30 min after meal) for 12 weeks intervention 3: PO, QD (30 min after meal) for 12 weeks

Protocol document: